Rangwala Reshma

Track

Insider profile

Performance

Overall performance
4.0
Performance over holding periods
4.0
30 days 90 days 120 days
Average return 21% 8.2% 15.1%
Success rate 80% 68% 82%
Transactions
11 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Rangwala Reshma's trades of Karyopharm Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-15 2026-05-14
S Sale
41,967 +8.1%
341.21
US$2,701,287 		41,967 +8.1% 341.21 US$2,701,287
2026-04-22 2026-04-21
S Sale
99,906 +17.3%
301.00
US$1,816,915 		99,906 +17.3% 301.00 US$1,816,915
2026-03-03 2026-03-02
S Sale
26,487 -10.7%
187.39
US$19,760 		26,487 -10.7% 187.39 US$19,760
2025-09-16 2025-09-15
S Sale
408 -1.4%
6.43
US$2,623 		408 -1.4% 6.43 US$2,623
2025-04-24 2025-04-23
S Sale
419 -1.4%
6.17
US$2,585 		419 -1.4% 6.17 US$2,585
2025-03-06 2025-03-04
S Sale
3,587 -10.9%
6.29
US$22,562 		3,587 -10.9% 6.29 US$22,562
2024-04-23 2024-04-22
S Sale
6,789 -1.9%
1.17
US$7,943 		6,789 -1.9% 1.17 US$7,943
2024-03-04 2024-03-01
S Sale
5,969 -1.7%
1.20
US$7,163 		5,969 -1.7% 1.20 US$7,163
2024-03-04 2024-02-29
S Sale
15,667 -4.2%
1.17
US$18,330 		15,667 -4.2% 1.17 US$18,330
2023-04-24 2023-04-20
S Sale
6,655 -4.0%
4.05
US$26,953 		6,655 -4.0% 4.05 US$26,953
2023-04-24 2023-04-20
S Sale
115 -0.1%
4.03
US$463 		115 -0.1% 4.03 US$463